Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 USD | +1.78% |
|
+16.58% | -1.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.93% | 32.69M | |
+20.40% | 127B | |
+24.48% | 117B | |
+25.44% | 27.67B | |
-18.48% | 20.33B | |
-15.17% | 16.79B | |
-16.28% | 15.63B | |
+13.13% | 14.84B | |
-47.10% | 14.65B | |
+56.66% | 14.43B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- HC Wainwright Adjusts Price Target on VYNE Therapeutics to $28 From $1.50, Maintains Buy Rating